PRO-PHARMACEUTICALS, INC. 8-K

Company

GALECTIN THERAPEUTICS INC

Filed

June 27, 2007

Period of Report

June 22, 2007

Accession Number

0001157523-07-006396

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →